This site contains promotional information intended only for healthcare professionals resident in the United Kingdom
Learn about ATTR-CM and uncover the differences between hereditary and wild-type ATTR-CM
Example of description text sitting alongside header
Explore a range of educational resources to support the diagnosis of ATTR-CM
Click here for Vyndaqel®▼ (tafamidis) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
The diagnosis of ATTR-CM may be delayed or missed. Therefore, having a high awareness of the red flags in important to facilitate an early diagnosis. Routine heart failure assessments, such as echocardiography and electrocardiography (ECG), along with advanced imaging techniques, can help you identify patients who may require further testing to make a diagnosis.1,2,3
ACEi, angiotensin-converting enzyme inhibitors; ARBs, angiotensin receptor blockers.
|Parasternal long-axis view5||Parasternal short-axis view7|
There are several additional signs/symptoms that could be clues for cardiac amyloidosis and ATTR-CM, which include:
This is a series of animated, educational modules that outline key background information on ATTR amyloidosis. This video reviews the importance of an early diagnosis of ATTR-CM.
Listen to our faculty of expert speakers and download resources including our interactive ATTR-CM Red Flags guide. You can also access and sign up to upcoming virtual events.
PP-VYN-GBR-1007. October 2022
Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.
PP-PFE-GBR-2809. October 2020
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search
for MHRA Yellow Card in Google Play or Apple App Store
Adverse events should also be reported to Pfizer Medical Information on 01304 616161
To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.
This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc
This website is brought to you by Pfizer Limited, a company registered in England
and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ
Copyright © 2023 Pfizer Limited. All rights reserved.
VAT registration number GB201048427
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021